“I think it’s actually going to enable them to grow revenue faster than they’re going to lose sales,” Finkelstein tells the Post. “It’s a win in terms of strategy, it’s a win in terms of PR, and it’s a win in terms of internal motivation. Most employees in a healthcare company would see this as a good thing.”
Read the full story, published 2/5/14 by The Washington Post.
NPR turned to Paul Argenti, a professor of corporate communication at Tuck, for his reaction to CVS’s decision to stop selling tobacco products. “They’ll end up getting more than $2 billion in reputational capital and kudos,” Argenti says. “How often is the president of the U.S. going to come out and say your company is great?"